| Literature DB >> 22918850 |
Behzad Nasiri Ahmadabadi1, Gholamhossein Hassanshahi, Hossein Khoramdelazad, Vahid Mirzaei, Seyed Mohammad Ali Sajadi, Masomeh Hajghani, Hassan Khodadadi, Reza Pourali, Mohammad Kazemi Arababadi, Derek Kennedy.
Abstract
Studies indicated that CC receptor 5 (CCR5), as a receptor for CC ligand 3, CCL4, and CCL5, plays important roles in the recruitment of T cytotoxic lymphocytes to the liver of chronic HBV (CHB)-infected patients. The main purpose of this study was to investigate the expression levels of CCR5 on the CD8(+) T lymphocytes of CHB patients. This clinical study was performed on 63 CHB patients and 96 healthy controls. Flow cytometric analysis was performed to examine the expression of CCR5 on CD8(+) T cells of CHB patients. Real-time PCR was also used for HBV-DNA quantification. The results of our study demonstrated that CCR5 expressing T cytotoxic cells were decreased significantly in CHB patients in comparison to healthy control. Based on our results, it can be concluded that the percent of CCR5(+)/CD8(+) T cells in Iranian CHB patients is significantly decreased, hence their migration to the infected liver, and HBV eradication from the hepatocytes is disrupted.Entities:
Mesh:
Substances:
Year: 2013 PMID: 22918850 DOI: 10.1007/s10753-012-9528-4
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092